EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Damien DRIOT •  doctorant


2022
Pas de publications

2021
  • Nguyen-Soenen J, Driot D, Verges Y, Dupouy J, Birebent J. Profil de délivrance des antidépresseurs chez l’enfant et l’adolescent en Midi-Pyrénées entre 2015 et 2017 [Patterns of antidepressant dispensing among children and adolescents between 2015 and 2017 in the French region of Midi-Pyrenees]. Rev Epidemiol Sante Publique. 2021 Feb;69(1):7-12. French. doi: 10.1016/j.respe.2020.10.008.
2020
  • Driot D, Nguyen-Soenen J, Costes M, Pomier M, Birebent J, Oustric S, Dupouy J.  [Management of child and adolescent depression in primary care: A systematic meta-review]. Encephale. 2020 Feb;46(1):41-54. French. doi:  10.1016/j.encep.2019.07.014.
     
  • Vergès Y, Driot D, Mesthé P, Rougé Bugat ME, Dupouy J, Poutrain JC. Collaboration Between GPs and Psychologists: Dissatisfaction from the Psychologists' Perspective-A Cross-Sectional Study. J Clin Psychol Med Settings. 2020 Jun;27(2):331-342. doi: 10.1016/j.encep.2019.07.014.
2019
  • Coley N Driot D, Ouhayoun S, Perinelli F, Grézy-Chabardès C, Birebent J, Bismuth M, Dupouy J. Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France. Therapie. 2019 Oct;74(5):537-546. doi: 10.1016/j.therap.2019.03.004.
     
  • Driot D, Jouanjus E, Oustric S, Dupouy J, Lapeyre-Mestre M. Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France. Br J Clin Pharmacol. 2019 Jun;85(6):1260-1269. doi: 10.1111/bcp.13892.
     
  • Driot D, Ouhayoun S, Perinelli F, Grézy-Chabardès C, Birebent J, Bismuth M, Dupouy J. Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France. Therapie. 2019 Oct;74(5):537-546. doi:  10.1016/j.therap.2019.03.004.